Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Pilot Study of Platelet Rich Plasma for Chronic Vascular Ulcers of the Lower Extremities
2015-002836-42Phase 2Active
- Sponsor
- Biobizkaia Health Research Institute
- Start
- Feb 2017
- Modality
- Adoptive Cell Transfer → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of autologous platelet-rich plasma in lower extremity ulcer, neurogenic ulcer and vascular ulcer, sponsored by Biobizkaia Health Research Institute. Primary endpoints: Feasibility of PRP treatment in Home Hospitalization service and Safety of PRP application. Started Feb 2017; status: active.
02
Drugs
autologous platelet-rich plasma
03
Conditions
lower extremity ulcerneurogenic ulcervascular ulcer
Beyond the preview
Go deeper on 2015-002836-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002836-42.